Table 2. Poor reported and Measured Physical Function Scores.

	N=1778	N	SF-36: PF (<=37)			PPT (<= 17)			6MW (<= 300)
			%	P-value**	N	%	P-value**	N	%	P-value**
Sex
Male	875	113	12.9	Ref	24	2.7	Ref	52	5.9	Ref
Female	903	138	15.3	0.15	25	2.8	0.97	59	6.5	0.61
Diagnosis
Leukemia1	805	90	11.2	Ref	15	1.9	Ref	37	4.6	Ref
Lymphoma	321	58	18.1	0.002	4	1.3	0.47	20	6.2	0.26
Bone Cancers 2	128	24	18.8	0.02	3	2.3	0.73	20	15.6	<0.001
CNS tumorˆ	141	31	22.0	<0.001	18	12.8	<0.001	13	9.2	0.02
Other3	383	48	12.5	0.50	9	2.4	0.58	21	5.5	0.51
Age at Diagnosis (Years)
0-4	696	87	12.5	Ref	26	3.7	Ref	44	6.3	Ref
5-9	434	53	12.2	0.89	12	2.8	0.38	21	4.8	0.30
10-14	380	63	16.6	0.06	6	1.6	0.05	27	7.1	0.62
≥15	268	48	17.9	0.03	5	1.9	0.14	19	7.1	0.67
Age at Study (Years)
18-29	660	64	9.7	Ref	22	3.3	Ref	33	5.0	Ref
30-39	726	100	13.8	0.02	14	1.9	0.10	46	6.3	0.28
40-49	334	67	20.1	<0.001	10	3.0	0.77	24	7.2	0.16
50-60	58	20	34.5	<0.001	3	5.2	0.46	8	13.8	0.01
Years Since Diagnosis (Years)
10-19	466	44	9.4	Ref	10	2.2	Ref	19	4.1	Ref
20-29	813	110	13.5	0.03	22	2.7	0.54	51	6.3	0.10
30-39	437	77	17.6	0.001	10	2.3	0.88	33	7.6	0.03
40-48	62	20	32.3	<0.001	7	11.3	0.002	8	12.9	0.01
BMI* (kg/m2)
<18.5	64	13	20.3	Ref	7	10.9	Ref	8	12.5	Ref
18.5-24.9	553	67	12.1	0.06	14	2.5	0.003	26	4.7	0.02
25.0-29.9	515	56	10.9	0.03	9	1.8	<0.001	29	5.6	0.03
30.0-34.9	339	51	15.0	0.29	7	2.1	0.003	21	6.2	0.11
35.0-39.9	164	28	17.1	0.57	6	3.7	0.05	11	6.7	0.16
>40	143	36	25.2	0.45	6	4.2	0.12	16	11.2	0.79

¹Acute lymphoblastic leukemia, chronic myeloid leukemia acute myeloid leukemia, other leukemia

²Ewing sarcoma, osteosarcoma

³Carcinoma, germ cell tumor, hepatoblastoma, melanoma, Wilms tumor, retinoblastoma, neuroblastoma, rhabdomyosarcoma, soft tissue sarcoma, other malignancy

^ˆCentral nervous system tumor

^*BMI=Body mass index, kg/m²=kilograms per meter squared

^**From Chi-Squared statistics or Fisher's Exact Test